+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Neonatal purpura fulminans in association with factor V R506Q mutation



Neonatal purpura fulminans in association with factor V R506Q mutation



Journal of Pediatrics 128(5 Part 1): 706-709



We report a case of neonatal purpura fulminans associated with activated protein C resistance. Analysis of DNA demonstrated heterozygosity for the factor V R506Q mutation. The neonate, at 8 hours of age, had progressive purpuric skin lesions and later had evidence of microvascular, hemorrhagic thrombosis in the brain. The baby was treated with fresh frozen plasma infusions and had complete resolution of the skin lesions and no apparent long-term complications. We suggest that activated protein C resistance testing be included in the initial evaluation of neonatal purpura fulminans.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 009081106

Download citation: RISBibTeXText

PMID: 8627449

DOI: 10.1016/s0022-3476(96)80142-9


Related references

A Novel Protein C Mutation Causing Neonatal Purpura Fulminans. Indian Pediatrics 53(11): 1019-1021, 2016

A novel mutation in the protein C gene causing neonatal purpura fulminans. American Journal of Human Genetics 71(4 Suppl.): 524, 2002

A novel homozygous missense mutation (Val 325-->Ala) in the protein C gene causing neonatal purpura fulminans. Blood Coagulation and Fibrinolysis 5(4): 651-653, 1994

A novel mutation c.1048A>T at codon 350(Lys>Stop) in PROC gene causing neonatal purpura fulminans. Blood Coagulation and Fibrinolysis 24(8): 890-892, 2013

Homozygous Factor V Leiden mutation in a child with meningococcal purpura fulminans. Pediatric Infectious Disease Journal 17(1): 87, 1998

Adult purpura fulminans and digital necrosis associated with sepsis and the factor V mutation. JAMA 280(21): 1829-1830, 1998

Hereditary angioedema associated with heterozygous factor V Leiden mutation in a patient with Purpura fulminans. International Archives of Allergy and Immunology 142(2): 175-178, 2007

A homozygous deletion/insertion mutation in the protein C (PROC) gene causing neonatal Purpura fulminans: prenatal diagnosis in an at-risk pregnancy. Blood Coagulation and Fibrinolysis 5(4): 647-649, 1994

Severe protein S deficiency associated with heterozygous factor V Leiden mutation in a child with purpura fulminans. Pediatric Hematology and Oncology 20(1): 1-5, 2003

Severe type I protein C deficiency with neonatal purpura fulminans due to a novel homozygous mutation in exon 6 of the protein C gene. Journal of Thrombosis and Haemostasis 4(5): 1152-1153, 2006

A novel factor V mutation causes a normal activated protein C ratio despite the presence of a heterozygous F5 R506Q (factor V Leiden) mutation. British Journal of Haematology 163(3): 414-417, 2013

Case 2: Is It Neonatal Purpura Fulminans?. Neoreviews 19(5): E301-E303, 2018

Disseminated intravascular coagulation and purpura fulminans in a patient with Candida sepsis. Biopsy of purpura fulminans as an aid to diagnosis of systemic Candida infection. American Journal of Medicine 80(4): 679-684, 1986

Neonatal purpura fulminans due to protein C deficiency. Archives of Disease in Childhood. Fetal and Neonatal Edition 100(5): F453, 2015

Diagnosis and management of neonatal purpura fulminans. Seminars in Fetal and Neonatal Medicine 16(6): 318-322, 2011